[Press Release] Bioneer announced on the 12th that it participated for the first time in the American Academy of Dermatology (AAD) held in Orlando, Florida, USA, from March 7th to 11th. The company set up a booth for its hair loss cosmetic product "CosmeRNA" and conducted marketing activities for the brand during the event.

The American Academy of Dermatology (AAD), established in 1939, is a globally renowned dermatology association with over 20,000 members from more than 100 countries, including the United States, Latin America, and Europe. Each year, dermatologists, researchers, and skin health experts from around the world gather at the AAD to share the latest research and clinical information on a wide range of topics, including the diagnosis and treatment of skin diseases, aesthetics, hair loss, and regenerative dermatology. The event serves as a crucial platform for knowledge exchange and collaboration. Additionally, the exhibition is strategically utilized by leading companies in the fields of dermatological pharmaceuticals, medical devices, and cosmetics as a key opportunity for market expansion and networking.

At this year's conference, Bioneer operated a CosmeRNA booth and promoted its clinic-exclusive product, CosmeRNA Intensive, and homecare product, CosmeRNA™ Revitalizing Tonic, to global dermatologists and industry professionals from regions such as the Americas, Latin America, and Europe.

Visitors to the booth showed significant interest and positive reactions to CosmeRNA's unique RNA-based technology, highlighting its effectiveness for women and the convenience of its application. The product requires only 10 minutes of use once a week or biweekly, which garnered particular attention and praise from attendees.

Through this conference, Bioneer engaged in business meetings with global Key Opinion Leader (KOL) dermatologists, who are early adopters, to validate the exceptional clinical efficacy of CosmeRNA. The company discussed various collaboration opportunities to expand its sales and distribution channels in the U.S., aiming to supply the product to dermatology clinics. These discussions underscored the potential for CosmeRNA to establish a strong presence in the American market.

Notably, Dr. Carlos Bautzer, a dermatologist and plastic surgeon based in São Paulo, Brazil, with over 70,000 followers, is an early adopter of CosmeRNA. After first encountering the product at IMCAS Paris in 2023, he has consistently used CosmeRNA and confirmed its outstanding clinical efficacy through exclusive use. Based on these results, he has decided to expand his collaboration with Bioneer. The company plans to leverage partnerships with Dr. Carlos and other global KOLs (Key Opinion Leaders) from key countries to further advance the marketing of CosmeRNA worldwide.

Additionally, Bioneer held an in-depth discussion with Dr. Ralf Paus, a world-renowned authority in hair research from the University of Miami Miller School of Medicine. The meeting focused on building a new product lineup that could revolutionize the field of hair loss treatment, exploring innovative approaches and potential advancements in the industry.

A Bioneer representative stated, "Participating in AAD 2025 was a meaningful opportunity to introduce CosmeRNA's innovative advancements to global dermatologists and industry leaders. It also allowed us to validate the product's exceptional efficacy and customer convenience of once-weekly use through feedback from leading experts who have adopted it early." They added, "Moving forward, we will continue to actively promote CosmeRNA's innovative value to customers in the U.S. and global markets, while expanding our supply chain and strengthening business collaborations."